Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

IGFBP-6 five years on; not so 'forgotten'?

Leon A Bach1

  • 1Department of Endocrinology and Diabetes, Alfred Hospital, Melbourne, Vic. 3004, Australia. leon.bach@med.monash.edu.au

Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society
|May 26, 2005
PubMed
Summary

Insulin-like growth factor binding protein (IGFBP)-6 specifically binds IGF-II, inhibiting certain cancers. Further research is needed to understand its potential IGF-independent actions and therapeutic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of intraoperative dexamethasone on glycaemic responses in people with diabetes mellitus: a preplanned analysis of the Perioperative ADministration of Dexamethasone and Infection trial.

British journal of anaesthesia·2026
Same author

Symptomatic hypocalcaemia after administration of denosumab and iron infusion in patients with normal and impaired renal function.

Internal medicine journal·2025
Same author

Incidence, prevalence, and predictors of osteoporotic fracture in adult lung transplant recipients.

JHLT open·2025
Same author

The Utility of Magnetic Resonance Imaging for Hypophysitis Secondary to Immune Checkpoint Inhibitor Use.

Clinical endocrinology·2025
Same author

Six months of hybrid closed-loop therapy improves diabetes-specific positive well-being, and reduces diabetes distress and fear of hypoglycemia: secondary analysis of a randomized controlled trial.

BMJ open diabetes research & care·2025
Same author

Results of an Australian trial of an automated insulin delivery (AID) system and other studies support likely benefit of AID use for many Australian adults with type 1 diabetes.

Internal medicine journal·2024

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cancer Research

Background:

  • Insulin-like growth factor binding protein (IGFBP)-6 exhibits unique IGF-II binding specificity.
  • IGFBP-6 demonstrates inhibitory effects on the growth of various IGF-II-dependent cancers, such as rhabdomyosarcoma, neuroblastoma, and colon cancer.

Purpose of the Study:

  • To investigate the dual role of IGFBP-6, encompassing both IGF-dependent and potential IGF-independent actions.
  • To explore the structural basis of IGFBP-6's IGF-II specificity and binding affinity.
  • To assess the therapeutic potential of IGFBP-6 in treating IGF-II-dependent tumors.

Main Methods:

  • Analysis of gene array data to understand IGFBP-6 regulation in various cellular contexts.
  • Structural analysis of the C-terminal domain of IGFBP-6 to identify IGF-II binding sites.

Related Experiment Videos

  • Review of existing literature on IGFBP-6's biological functions and interactions.

    • Main Results:

    • IGFBP-6 inhibits the growth of several IGF-II-dependent cancers.
    • Gene array studies suggest IGFBP-6's involvement in antiproliferative processes, though some studies indicate counter-regulatory roles.
    • The C-terminal domain of IGFBP-6, featuring a thyroglobulin type 1 fold, is crucial for IGF-II binding specificity and affinity.

    Conclusions:

    • IGFBP-6 is a significant inhibitor of IGF-II-dependent cancers.
    • Further research is warranted to elucidate the precise mechanisms of IGFBP-6's IGF-independent actions.
    • Structural insights into IGFBP-6 enhance understanding and highlight its potential as a therapeutic agent for specific tumors.